26262991|t|Antidiabetic Effect of Galantamine: Novel Effect for a Known Centrally Acting Drug.
26262991|a|The cholinergic anti-inflammatory pathway is one of the putative biochemical pathways that link diabetes with Alzheimer disease. Hence, we aimed to verify the potential antidiabetic effect of galantamine, unveil the possible mechanisms and evaluate its interaction with vildagliptin. The n5-STZ rat model was adopted and the diabetic animals were treated with galantamine and/or vildagliptin for 4 weeks. Galantamine lowered the n5-STZ-induced elevation in body weight, food/water intake, serum levels of glucose, fructosamine, and ALT/AST, as well as AChE in the tested organs. Moreover, it modulated successfully the lipid profile assessed in serum, liver, and muscle, and increased serum insulin level, as well as % beta-cell function, in a pattern similar to that of vildagliptin. Additionally, galantamine confirmed its antioxidant (Nrf2, TAC, MDA), anti-inflammatory (NF-kappaB, TNF-alpha, visfatin, adiponectin) and anti-apoptotic (caspase-3, cytochrome c) capabilities by altering the n5-STZ effect on all the aforementioned parameters. On the molecular level, galantamine/vildagliptin have improved the insulin (p-insulin receptor, p-Akt, GLUT4/GLUT2) and Wnt/beta-catenin (p-GSK-3beta, beta-catenin) signaling pathways. On almost all parameters, the galantamine effects surpassed that of vildagliptin, while the combination regimen showed the best effects. The present results clearly proved that galantamine modulated glucose/lipid profile possibly through its anti-oxidant, -apoptotic, -inflammatory and -cholinesterase properties. These effects could be attributed partly to the enhancement of insulin and Wnt/beta-catenin signaling pathways. Galantamine can be strongly considered as a potential antidiabetic agent and as an add-on therapy with other oral antidiabetics. 
26262991	23	34	Galantamine	Chemical	MESH:D005702
26262991	105	117	inflammatory	Disease	MESH:D007249
26262991	180	188	diabetes	Disease	MESH:D003920
26262991	194	211	Alzheimer disease	Disease	MESH:D000544
26262991	276	287	galantamine	Chemical	MESH:D005702
26262991	354	366	vildagliptin	Chemical	MESH:D000077597
26262991	375	378	STZ	Chemical	MESH:D013311
26262991	379	382	rat	Species	10116
26262991	409	417	diabetic	Disease	MESH:D003920
26262991	444	455	galantamine	Chemical	MESH:D005702
26262991	463	475	vildagliptin	Chemical	MESH:D000077597
26262991	489	500	Galantamine	Chemical	MESH:D005702
26262991	516	519	STZ	Chemical	MESH:D013311
26262991	589	596	glucose	Chemical	MESH:D005947
26262991	598	610	fructosamine	Chemical	MESH:D019270
26262991	636	640	AChE	Gene	83817
26262991	703	708	lipid	Chemical	MESH:D008055
26262991	855	867	vildagliptin	Chemical	MESH:D000077597
26262991	883	894	galantamine	Chemical	MESH:D005702
26262991	922	926	Nrf2	Gene	83619
26262991	928	931	TAC	Gene	24806
26262991	933	936	MDA	Chemical	MESH:D015104
26262991	944	956	inflammatory	Disease	MESH:D007249
26262991	969	978	TNF-alpha	Gene	24835
26262991	980	988	visfatin	Gene	297508
26262991	990	1001	adiponectin	Gene	246253
26262991	1023	1032	caspase-3	Gene	25402
26262991	1080	1083	STZ	Chemical	MESH:D013311
26262991	1153	1164	galantamine	Chemical	MESH:D005702
26262991	1165	1177	vildagliptin	Chemical	MESH:D000077597
26262991	1207	1223	insulin receptor	Gene	24954
26262991	1227	1230	Akt	Gene	24185
26262991	1232	1237	GLUT4	Gene	25139
26262991	1238	1243	GLUT2	Gene	25351
26262991	1249	1252	Wnt	Gene	114487
26262991	1253	1265	beta-catenin	Gene	84353
26262991	1269	1278	GSK-3beta	Gene	84027
26262991	1280	1292	beta-catenin	Gene	84353
26262991	1344	1355	galantamine	Chemical	MESH:D005702
26262991	1382	1394	vildagliptin	Chemical	MESH:D000077597
26262991	1491	1502	galantamine	Chemical	MESH:D005702
26262991	1513	1520	glucose	Chemical	MESH:D005947
26262991	1521	1526	lipid	Chemical	MESH:D008055
26262991	1583	1595	inflammatory	Disease	MESH:D007249
26262991	1601	1615	cholinesterase	Gene	65036
26262991	1703	1706	Wnt	Gene	114487
26262991	1707	1719	beta-catenin	Gene	84353
26262991	1740	1751	Galantamine	Chemical	MESH:D005702
26262991	Negative_Correlation	MESH:D005702	MESH:D007249
26262991	Negative_Correlation	MESH:D005702	25402
26262991	Association	MESH:D005702	65036
26262991	Negative_Correlation	MESH:D005702	MESH:D005947
26262991	Positive_Correlation	MESH:D013311	MESH:D019270
26262991	Negative_Correlation	MESH:D000077597	MESH:D003920
26262991	Association	MESH:D005702	MESH:D008055
26262991	Association	MESH:D005702	114487
26262991	Negative_Correlation	MESH:D005702	297508
26262991	Positive_Correlation	MESH:D000077597	25351
26262991	Positive_Correlation	MESH:D000077597	114487
26262991	Association	MESH:D005702	25351
26262991	Positive_Correlation	MESH:D005947	MESH:D013311
26262991	Positive_Correlation	MESH:D000077597	24954
26262991	Positive_Correlation	MESH:D000077597	25139
26262991	Negative_Correlation	MESH:D005702	83817
26262991	Association	MESH:D005702	24954
26262991	Positive_Correlation	MESH:D013311	MESH:D003920
26262991	Association	MESH:D005702	25139
26262991	Association	MESH:D000077597	24185
26262991	Cotreatment	MESH:D000077597	MESH:D005702
26262991	Positive_Correlation	MESH:D013311	83817
26262991	Negative_Correlation	MESH:D005702	24835
26262991	Negative_Correlation	MESH:D005702	MESH:D013311
26262991	Association	MESH:D000077597	84027
26262991	Negative_Correlation	MESH:D005702	MESH:D019270
26262991	Negative_Correlation	MESH:D005702	MESH:D003920
26262991	Association	MESH:D005702	84027
26262991	Association	MESH:D005947	MESH:D007249
26262991	Association	MESH:D000077597	84353
26262991	Association	MESH:D005702	84353
26262991	Association	MESH:D005702	24185

